Latest Cost Management News

iCandy Interactive reports a remarkable 105% increase in net cash flow for Q4 2024 despite a 22% drop in cash receipts, driven by strategic expansions and operational efficiencies amid ongoing legal disputes.

Lykos Metals Limited reports significant high-grade mineral findings at its Sinjakovo Project and extends its Jezero exploration permit, alongside key board appointments and cost restructuring.

Inventis Limited reported robust Q2 progress with over $5.7 million in confirmed orders and a $2.5 million capital raise underway in the US, signaling strong momentum in its technology-driven growth strategy.

Freehill Mining has reported a record-breaking December quarter with gross sales doubling to $954,000 and a significant improvement in operating cash flow, positioning the company for sustained growth in 2025.

ReNu Energy reports progress on a management buyout proposal for its hydrogen subsidiary and completes sale of legacy geothermal assets, signaling a strategic pivot and ongoing capital challenges.

Chimeric Therapeutics has dosed the first three patients in its Phase 1/2 CHM CDH17 CAR-T trial targeting gastrointestinal cancers, alongside advancing its AML and NK cell therapy programs. The company also secured $5 million in funding and appointed Dr Rebecca McQualter as CEO.

Vectus Biosystems reports completion of Phase Ib trials for its lead drug VB0004 and a robust cash position bolstered by a significant R&D tax refund, setting the stage for licensing discussions.

Peninsula Energy Limited reported a substantial cash outflow in the December 2024 quarter, driven by significant investing activity related to its Lance Projects. The company is actively pursuing additional funding to support upcoming production scale-up.

Opthea Limited reports steady progress in its Phase 3 trials for sozinibercept, a novel treatment for wet AMD, supported by a strong cash position and a recent R&D tax incentive.

Althea Group Holdings reported a 20% increase in customer receipts to $9.01 million for Q2 FY25, while addressing governance lapses and reviewing its FY25 guidance. The company is advancing operational improvements and cost savings as it prepares for a pivotal Federal Court hearing.

Nova Eye Medical reports a robust 39% increase in global sales driven by strong U.S. market demand and secures $6.6 million in fresh capital to fuel expansion and product development.

American West Metals has reported a substantial increase in its Storm Copper Project's mineral resource, alongside new high-grade copper discoveries and a successful A$7 million capital raise to fund further exploration and development.